undamentalytics Newsletter
Sign in

Phreesia, Inc. key statistics and ratios

In fiscal 2026, Phreesia, Inc. had return on equity of 0.8% and a net margin of 0.5%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Jan 20182019Jan 20192020Jan 20202021Jan 20212022Jan 20222023Jan 20232024Jan 20242025Jan 20252026Jan 2026LTMJul 2026
Net margin−22.8%−15.1%−16.3%−18.4%−55.4%−62.7%−38.4%−13.9%0.5%2.1%
Return on equity———−14.9%−34.7%−50.0%−50.8%−22.7%0.8%2.9%
Return on assets—−25.4%−18.6%−11.2%−28.8%−40.7%−37.0%−15.4%0.4%1.6%
R&D as % of revenue14.3%14.4%14.9%15.2%24.5%32.5%31.5%28.0%25.3%22.9%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

6 of 7 checks passed · July 31, 2026
What it owns · $647m
Short-term assets $254mLonger-term assets $393m
What it owes, and who funded it · $647m
Short-term liabilities $144mLonger-term liabilities $131mShareholders' equity $372m
  • Short-term assets cover short-term liabilities $254m of assets due within a year against $144m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $254m short-term assets against $131m of longer-dated liabilities.
  • More cash than debt $75m of cash against $1m of debt.
  • Debt below 40% of shareholders' equity Debt is 0% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 0% to 0% over five years.
  • A year's operating cash flow covers at least 20% of debt $91m of operating cash flow against $1m of debt.
  • Operating profit covers interest at least five times over Operating income of $13m against $10m of interest.

From Phreesia, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

11 /100

Weak moat

How hard Phreesia's competitive advantage looks for rivals to wear away, judged from 8 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median -13.0% of total assets over 8 years.

  • Durability 10 / 20

    Operating margin has been a median -19.4%; its worst year was -73.1%.

  • Cash conversion 3 / 20

    Free cash flow was positive in 2 of 8 years, at a median -6.7% of revenue.

  • Discipline 0 / 20

    The diluted share count rose 39.6% over five years; stock-based pay has been a median 13.3% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (16 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: PHR vs WGSDOCS vs PHRGDRX vs PHR

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Phreesia, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Phreesia, Inc.